Cocrystal Pharma (COCP) Operating Leases (2019 - 2026)
Cocrystal Pharma (COCP) posted Operating Leases of $1.4 million for Q1 2026, up 21.61% sequentially from $1.2 million in Q4 2025, and little changed YoY from $1.4 million in Q1 2025.
Cocrystal Pharma (COCP) Operating Leases (2019 - 2026) Analysis & Trends
Cocrystal Pharma has reported Operating Leases for 8 years, with the latest figure at $1.4 million in Q1 2026.
- Quarterly Operating Leases changed 0.0% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (changed 0.0% YoY) and the FY2025 annual result came in at $1.2 million, down 22.19% from the prior year.
- Operating Leases advanced to $1.4 million in Q1 2026 per COCP's latest filing, from $1.2 million in the prior quarter.
- Over five years, Operating Leases peaked at $1.9 million in Q3 2024 and troughed at $10000.0 in Q2 2023.
- A 5-year average of $1.0 million and a median of $1.4 million in 2025 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2023 and 2024: Operating Leases sank 97.49% in 2023, then jumped 15190.0% in 2024.
- Over 5 years, Operating Leases stood at $57000.0 in 2022, then soared by 2729.82% to $1.6 million in 2023, then fell by 6.7% to $1.5 million in 2024, then decreased by 22.19% to $1.2 million in 2025, then rose by 21.61% to $1.4 million in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $1.4 million, $1.2 million, and $1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cocrystal Pharma | 15.65 Mn | 13.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.34 Mn |
| Mar 31, 2026 | 1.42 Mn |
| Dec 31, 2025 | 1.17 Mn |
| Sep 30, 2025 | 1.58 Mn |
| Jun 30, 2025 | 1.66 Mn |
| Mar 31, 2025 | 1.42 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Sep 30, 2024 | 1.88 Mn |
| Jun 30, 2024 | 1.53 Mn |
| Mar 31, 2024 | 1.82 Mn |
| Dec 31, 2023 | 1.61 Mn |
| Sep 30, 2023 | 118,000.00 |
| Jun 30, 2023 | 10,000.00 |
| Mar 31, 2023 | 234,000.00 |
| Dec 31, 2022 | 57,000.00 |
| Sep 30, 2022 | 346,000.00 |
| Jun 30, 2022 | 398,000.00 |
| Mar 31, 2022 | 234,000.00 |
| Dec 31, 2021 | 291,000.00 |
| Sep 30, 2021 | 344,000.00 |